Ipamorelin CJC-1295 No Dac Blend Nasal Spray

Ipamorelin CJC-1295 No DAC Blend Nasal Spray is a dual-peptide research formulation available at Direct Anti Peptide, supplied at ≥98% purity and engineered for advanced laboratory investigation into growth hormone modulation and metabolic signaling pathways. This nasal spray delivery format is designed to support researchers exploring enhanced bioavailability and rapid transmucosal absorption kinetics in controlled in vitro and in vivo study environments. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

The Ipamorelin CJC-1295 No DAC Blend Nasal Spray represents a sophisticated combination of two well-characterized research peptides — Ipamorelin, a selective growth hormone secretagogue (GHS), and CJC-1295 Without DAC, a growth hormone-releasing hormone (GHRH) analogue. Together, these peptides are of significant interest to researchers investigating synergistic GH-axis modulation, pulsatile growth hormone release patterns, and downstream metabolic effects. The nasal spray delivery format offers a novel research model for studying transmucosal peptide absorption compared to conventional reconstituted injectable formulations.

Peptide Structure & Amino Acid Sequence

Ipamorelin is a pentapeptide with the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂, classified as a ghrelin receptor agonist and growth hormone secretagogue. It is noted in published research literature for its high selectivity toward GH release with minimal observed influence on cortisol or prolactin secretion, making it a focused tool for GH-axis research.

CJC-1295 Without DAC (also referred to as Modified GRF 1-29 or Mod GRF 1-29) is a 29-amino acid analogue of endogenous GHRH, engineered with specific amino acid substitutions to enhance enzymatic stability and extend its half-life relative to native GHRH. Its sequence modifications confer resistance to dipeptidyl peptidase-IV (DPP-IV) degradation, a property of significant interest in pharmacokinetic research studies.

Chemical & Physical Characteristics

• Formulation Type: Dual-peptide nasal spray blend
• Component Peptides: Ipamorelin + CJC-1295 Without DAC
• Purity: ≥98% (HPLC-verified)
• Appearance: Clear to slightly opalescent aqueous solution
• Molecular Classification: Growth hormone secretagogue / GHRH analogue blend
• Delivery Format: Intranasal spray for transmucosal research applications

Purity & Analytical Verification (HPLC & MS)

Every batch of Ipamorelin CJC-1295 No DAC Blend Nasal Spray produced and distributed by Direct Anti Peptide undergoes rigorous analytical testing prior to release. High-Performance Liquid Chromatography (HPLC) is employed to confirm peptide purity at ≥98%, while Mass Spectrometry (MS) validation verifies correct molecular weight and structural identity for both Ipamorelin and CJC-1295 Without DAC components. Researchers can be confident that the blend composition is analytically consistent and batch-reproducible.

Quality Control & Lyophilization Integrity

Individual peptide components are lyophilized under controlled conditions prior to blending and formulation into the nasal spray vehicle. Lyophilization removes residual moisture to preserve peptide structural integrity during storage and transit. The final nasal spray formulation undergoes quality control checks for pH, particulate matter, and blend homogeneity, ensuring researchers receive a consistent, research-grade product from Direct Anti Peptide.

Safety, Handling & Laboratory Precautions

This product is strictly intended for use by qualified research professionals in licensed laboratory settings. Standard laboratory personal protective equipment (PPE), including gloves, eye protection, and appropriate lab attire, should be worn when handling this formulation. Researchers should follow all applicable institutional biosafety protocols and local regulations governing the handling of research-grade peptide compounds. This product is not intended for self-administration, human consumption, or any clinical application.

Reconstitution, Packaging & Storage

The Ipamorelin CJC-1295 No DAC Blend Nasal Spray is supplied as a ready-to-use liquid formulation in a metered nasal spray dispenser. No additional reconstitution is required. Upon receipt, the product should be stored at 2–8°C (refrigerated) and protected from direct light and heat. Researchers should refer to the accompanying certificate of analysis (CoA) for specific storage conditions and expiry information. Avoid repeated freeze-thaw cycles to maintain formulation stability.

Intended Research Use & Market Positioning

This blend is positioned as a premium research tool for scientists and institutions investigating growth hormone secretagogue biology, GHRH analogue pharmacokinetics, metabolic health modelling, and transmucosal peptide delivery mechanisms. The nasal spray format offers a unique research variable compared to lyophilized peptide vials, enabling comparative absorption and bioavailability studies. Direct Anti Peptide supplies this product exclusively for in vitro and preclinical research applications.

Ordering, Availability & Fulfillment

Buy Ipamorelin CJC-1295 No DAC Blend Nasal Spray online today from Direct Anti Peptide, your trusted source for high-purity research peptides for sale at competitive prices. We offer fast order processing, secure checkout, and reliable international fulfillment. Order now to take advantage of our best price guarantee and consistent stock availability across all peptide blend formats.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. Ipamorelin CJC-1295 No DAC Blend Nasal Spray is sold exclusively as a laboratory research reagent by Direct Anti Peptide. All purchasers are solely responsible for ensuring compliance with applicable local, national, and international laws and regulations governing the procurement, handling, and use of research peptides. Direct Anti Peptide makes no therapeutic, medical, or health claims regarding this or any other product in our catalogue.